Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a study to assess the effects of darapladib on the cardiac conduction of the heart as
compared to placebo and moxifloxacin. This a four period crossover design with each period
lasting about 10 days. There will be a 7 to 10 day wash out in between each period.